NCT07576231 Effects of Sacral Release Technique and Lumbar Mobilization in Primary Dysmenorrhea.
| NCT ID | NCT07576231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Dysmenorrhea |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2025-10-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the comparative effects of sacral release technique and lumbar mobilization in pain, symptoms severity and quality of life in primary dysmenorrhea.
Eligibility Criteria
Inclusion Criteria: * Unmarried female * Diagnosed with primary dysmenorrhea through WaLIDD Score * Regular menstrual cycles (21-35 days) * Pain score of \> 4 on the Numerical Pain Rating Scale (NPRS) during menstruation Exclusion Criteria: * Any pelvic inflammatory disease * Obesity * PCOS * Spinal deformity * Lumber radiculopathy * Heavy menstrual bleeding (menorrhagia) * Irregular menstrual cycles * Spine trauma and coccyx pain * History of pelvic or spinal surgery currently on hormonal therapy or other ongoing physiotherapy for dysmenorrhea
Contact & Investigator
sobia ghafoor, t-DPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576231 clinical trial?
This trial is open to female participants only, aged 13 Years or older, up to 19 Years, studying Dysmenorrhea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576231 currently recruiting?
Yes, NCT07576231 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07576231 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07576231 clinical trial?
NCT07576231 is sponsored by Riphah International University. The principal investigator is sobia ghafoor, t-DPT at Riphah International University. The trial plans to enroll 46 participants.